Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples